Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

Multirefractory primary immune thrombocytopenia; targeting the decreased sialic acid content.

Revilla N, Corral J, Miñano A, Mingot-Castellano ME, Campos RM, Velasco F, Gonzalez N, Galvez E, Berrueco R, Fuentes I, Gonzalez-Lopez TJ, de la Morena-Barrio ME, Gonzalez-Porras JR, Vicente V, Lozano ML.

Platelets. 2018 Oct 8:1-9. doi: 10.1080/09537104.2018.1513476. [Epub ahead of print]

PMID:
30296193
2.

Sitosterolemia: diagnosis, metabolic and hematological abnormalities, cardiovascular disease and management.

Bastida JM, Giros ML, Benito R, Janusz K, Hernandez-Rivas JM, Gonzalez-Porras JR.

Curr Med Chem. 2018 Jul 5. doi: 10.2174/0929867325666180705145900. [Epub ahead of print]

PMID:
29984642
3.

Eltrombopag in immune thrombocytopenia: efficacy review and update on drug safety.

Gonzalez-Porras JR, Bastida JM.

Ther Adv Drug Saf. 2018 Jun;9(6):263-285. doi: 10.1177/2042098618769587. Epub 2018 Apr 19. Review.

4.

Hemorrhagic pericardial effusion as the debut of acquired hemophilia in a chronic lymphocytic leukemia patient: A case report, and a review of acquired hemophilia A-related hematological malignancies.

Bastida JM, Cano-Mozo MT, Lopez-Cadenas F, Vallejo VE, Merchán S, Santos-Montón C, González-Calle D, Carrillo J, Martín AA, Torres-Hernández JA, González M, Martín-Herrero F, Pabón P, González-Porras JR.

Medicine (Baltimore). 2017 Nov;96(47):e8669. doi: 10.1097/MD.0000000000008669.

5.

C3G promotes a selective release of angiogenic factors from activated mouse platelets to regulate angiogenesis and tumor metastasis.

Martín-Granado V, Ortiz-Rivero S, Carmona R, Gutiérrez-Herrero S, Barrera M, San-Segundo L, Sequera C, Perdiguero P, Lozano F, Martín-Herrero F, González-Porras JR, Muñoz-Chápuli R, Porras A, Guerrero C.

Oncotarget. 2017 Nov 6;8(67):110994-111011. doi: 10.18632/oncotarget.22339. eCollection 2017 Dec 19.

6.

Introducing high-throughput sequencing into mainstream genetic diagnosis practice in inherited platelet disorders.

Bastida JM, Lozano ML, Benito R, Janusz K, Palma-Barqueros V, Del Rey M, Hernández-Sánchez JM, Riesco S, Bermejo N, González-García H, Rodriguez-Alén A, Aguilar C, Sevivas T, López-Fernández MF, Marneth AE, van der Reijden BA, Morgan NV, Watson SP, Vicente V, Hernández-Rivas JM, Rivera J, González-Porras JR.

Haematologica. 2018 Jan;103(1):148-162. doi: 10.3324/haematol.2017.171132. Epub 2017 Oct 5.

7.

[Clinical perspectives on the management of bleeding in patients on oral anticoagulants: the DECOVER Study (DElphi Consensus on oral COagulation and therapy action reVERsal)].

Vicente V, Martín A, Lecumberri R, Coll-Vinent B, Suero C, González-Porras JR, Marco P, Mateo J, Roldán V, Soulard S, Crespo C, Camats M; Grupo DECOVER.

Emergencias. 2017 Feb;29(1):18-26. Spanish.

8.

Mesenchymal stromal cells (MSC) from JAK2+ myeloproliferative neoplasms differ from normal MSC and contribute to the maintenance of neoplastic hematopoiesis.

Ramos TL, Sánchez-Abarca LI, Rosón-Burgo B, Redondo A, Rico A, Preciado S, Ortega R, Rodríguez C, Muntión S, Hernández-Hernández Á, De Las Rivas J, González M, González Porras JR, Del Cañizo C, Sánchez-Guijo F.

PLoS One. 2017 Aug 10;12(8):e0182470. doi: 10.1371/journal.pone.0182470. eCollection 2017.

9.

Identification of two novel mutations in RASGRP2 affecting platelet CalDAG-GEFI expression and function in patients with bleeding diathesis.

Sevivas T, Bastida JM, Paul DS, Caparros E, Palma-Barqueros V, Coucelo M, Marques D, Ferrer-Marín F, González-Porras JR, Vicente V, Hernández-Rivas JM, Watson SP, Lozano ML, Bergmeier W, Rivera J.

Platelets. 2018 Mar;29(2):192-195. doi: 10.1080/09537104.2017.1336214. Epub 2017 Aug 1.

10.

Two novel variants of the ABCG5 gene cause xanthelasmas and macrothrombocytopenia: a brief review of hematologic abnormalities of sitosterolemia.

Bastida JM, Benito R, Janusz K, Díez-Campelo M, Hernández-Sánchez JM, Marcellini S, Girós M, Rivera J, Lozano ML, Hortal A, Hernández-Rivas JM, González-Porras JR.

J Thromb Haemost. 2017 Sep;15(9):1859-1866. doi: 10.1111/jth.13777. Epub 2017 Aug 5. Review.

PMID:
28696550
11.

Efficacy and safety of eltrombopag in persistent and newly diagnosed ITP in clinical practice.

González-López TJ, Fernández-Fuertes F, Hernández-Rivas JA, Sánchez-González B, Martínez-Robles V, Alvarez-Román MT, Pérez-Rus G, Pascual C, Bernat S, Arrieta-Cerdán E, Aguilar C, Bárez A, Peñarrubia MJ, Olivera P, Fernández-Rodríguez A, de Cabo E, García-Frade LJ, González-Porras JR.

Int J Hematol. 2017 Oct;106(4):508-516. doi: 10.1007/s12185-017-2275-4. Epub 2017 Jun 30.

PMID:
28667351
12.

Top-level sport in athletes with severe haemophilia A.

Gonzalez-Porras JR, Lopez-Cadenas F, Alberca I, Bastida JM.

Haemophilia. 2017 Jul;23(4):e391-e393. doi: 10.1111/hae.13283. Epub 2017 Jun 2. No abstract available.

PMID:
28574636
13.

Use of eltrombopag for secondary immune thrombocytopenia in clinical practice.

González-López TJ, Alvarez-Román MT, Pascual C, Sánchez-González B, Fernández-Fuentes F, Pérez-Rus G, Hernández-Rivas JA, Bernat S, Bastida JM, Martínez-Badas MP, Martínez-Robles V, Soto I, Olivera P, Bolaños E, Alonso R, Entrena L, Gómez-Nuñez M, Alonso A, Yera Cobo M, Caparrós I, Tenorio M, Arrieta-Cerdán E, Lopez-Ansoar E, García-Frade J, González-Porras JR.

Br J Haematol. 2017 Sep;178(6):959-970. doi: 10.1111/bjh.14788. Epub 2017 Jun 1.

PMID:
28573819
14.

Novel approaches for diagnosing inherited platelet disorders.

Bastida Bermejo JM, Hernández-Rivas JM, González-Porras JR.

Med Clin (Barc). 2017 Jan 20;148(2):71-77. doi: 10.1016/j.medcli.2016.09.014. Epub 2016 Oct 27. Review. English, Spanish.

PMID:
28218058
15.

Development and validation of a new questionnaire measuring treatment satisfaction in patients with non-valvular atrial fibrillation: SAFUCA®.

Ruiz MA, González-Porras JR, Aranguren JL, Franco E, Villasante F, Tuñón J, González-López TJ, de Salas-Cansado M, Soto J.

Qual Life Res. 2017 Mar;26(3):767-778. doi: 10.1007/s11136-016-1474-4. Epub 2016 Dec 18.

PMID:
27990608
16.

Application of a molecular diagnostic algorithm for haemophilia A and B using next-generation sequencing of entire F8, F9 and VWF genes.

Bastida JM, González-Porras JR, Jiménez C, Benito R, Ordoñez GR, Álvarez-Román MT, Fontecha ME, Janusz K, Castillo D, Fisac RM, García-Frade LJ, Aguilar C, Martínez MP, Bermejo N, Herrero S, Balanzategui A, Martin-Antorán JM, Ramos R, Cebeiro MJ, Pardal E, Aguilera C, Pérez-Gutierrez B, Prieto M, Riesco S, Mendoza MC, Benito A, Hortal Benito-Sendin A, Jiménez-Yuste V, Hernández-Rivas JM, García-Sanz R, González-Díaz M, Sarasquete ME.

Thromb Haemost. 2017 Jan 5;117(1):66-74. doi: 10.1160/TH16-05-0375. Epub 2016 Oct 13.

PMID:
27734074
17.

Identification of a new potential mechanism responsible for severe bleeding in myeloma: immunoglobulins bind the heparin binding domain of antithrombin activating this endogenous anticoagulant.

Martínez-Martínez I, González-Porras JR, Cebeira MJ, de Arriba F, Espín S, Bohdan N, Corrales FJ, Corral J, Vicente V.

Haematologica. 2016 Oct;101(10):e423-e426. Epub 2016 Jun 16. No abstract available.

18.

Real-life management of primary immune thrombocytopenia (ITP) in adult patients and adherence to practice guidelines.

Lozano ML, Revilla N, Gonzalez-Lopez TJ, Novelli S, González-Porras JR, Sánchez-Gonzalez B, Bermejo N, Pérez S, Lucas FJ, Álvarez MT, Arilla MJ, Perera M, do Nascimento J, Campos RM, Casado LF, Vicente V.

Ann Hematol. 2016 Jun;95(7):1089-98. doi: 10.1007/s00277-016-2665-3. Epub 2016 Apr 21.

PMID:
27098812
19.

Hsp70 protects from stroke in atrial fibrillation patients by preventing thrombosis without increased bleeding risk.

Allende M, Molina E, Guruceaga E, Tamayo I, González-Porras JR, Gonzalez-López TJ, Toledo E, Rabal O, Ugarte A, Roldán V, Rivera J, Oyarzabal J, Montes R, Hermida J.

Cardiovasc Res. 2016 Jun 1;110(3):309-18. doi: 10.1093/cvr/cvw049. Epub 2016 Mar 14.

PMID:
26976620
20.

Management patterns and outcomes in symptomatic venous thromboembolism following allogeneic hematopoietic stem cell transplantation. A 15-years experience at a single center.

Labrador J, González-Rivero J, Monroy R, Lozano FS, López-Corral L, Caballero MD, Bastida JM, González-Porras JR.

Thromb Res. 2016 Jun;142:52-6. doi: 10.1016/j.thromres.2016.02.016. Epub 2016 Feb 18.

PMID:
26922092
21.

Design and application of a 23-gene panel by next-generation sequencing for inherited coagulation bleeding disorders.

Bastida JM, Del Rey M, Lozano ML, Sarasquete ME, Benito R, Fontecha ME, Fisac R, García-Frade LJ, Aguilar C, Martínez MP, Pardal E, Aguilera C, Pérez B, Ramos R, Cardesa MR, Martin-Antorán JM, Silvestre LA, Cebeira MJ, Bermejo N, Riesco S, Mendoza MC, García-Sanz R, González-Díaz M, Hernández-Rivas JM, González-Porras JR.

Haemophilia. 2016 Jul;22(4):590-7. doi: 10.1111/hae.12908. Epub 2016 Feb 15.

PMID:
26879396
22.

Self-administered versus interview-based questionnaires among patients with intermittent claudication: Do they give different results? A cross-sectional study.

Lozano F, Lobos JM, March JR, Carrasco E, Barros MB, González-Porras JR.

Sao Paulo Med J. 2016 Jan-Feb;134(1):63-9. doi: 10.1590/1516-3180.2015.01733009. Epub 2016 Jan 19.

23.

Short Leukocyte Telomere Length Is Associated With Cardioembolic Stroke Risk in Patients With Atrial Fibrillation.

Allende M, Molina E, González-Porras JR, Toledo E, Lecumberri R, Hermida J.

Stroke. 2016 Mar;47(3):863-5. doi: 10.1161/STROKEAHA.115.011837. Epub 2016 Jan 19.

PMID:
26786116
24.

Eltrombopag safety and efficacy for primary chronic immune thrombocytopenia in clinical practice.

González-López TJ, Alvarez-Román MT, Pascual C, Sánchez-González B, Fernández-Fuentes F, Jarque I, Pérez-Rus G, Pérez-Crespo S, Bernat S, Hernández-Rivas JA, Andrade MM, Cortés M, Gómez-Nuñez M, Olivera P, Martínez-Robles V, Fernández-Rodríguez A, Fuertes-Palacio MA, Fernández-Miñano C, de Cabo E, Fisac R, Aguilar C, Bárez A, Peñarrubia MJ, García-Frade LJ, González-Porras JR.

Eur J Haematol. 2016 Sep;97(3):297-302. doi: 10.1111/ejh.12725. Epub 2016 Jan 27.

PMID:
26709028
25.

Identification of new markers of recurrence in patients with unprovoked deep vein thrombosis by gene expression profiling: the retro study.

Montes R, Guruceaga E, González-Porras JR, Reverter JC, Marco P, Pina E, Páramo JA, Hermida J, Lecumberri R; Grupo de Trabajo de Patología Trombótica de la Sociedad Española de Trombosis y Hemostasia (SETH).

Eur J Haematol. 2016 Aug;97(2):128-36. doi: 10.1111/ejh.12692. Epub 2015 Nov 26.

PMID:
26505263
26.

Influence of UGT2B7, CYP3A4, and OPRM1 Gene Polymorphisms on Transdermal Buprenorphine Pain Control in Patients with Critical Lower Limb Ischemia Awaiting Revascularization.

Blanco F, Muriel C, Labrador J, Gonzalez-Porras JR, Gonzalez-Sarmiento R, Lozano FS.

Pain Pract. 2016 Sep;16(7):842-9. doi: 10.1111/papr.12343. Epub 2015 Sep 26.

PMID:
26407542
27.

Management of side effects of BCR/ABL-negative chronic myeloproliferative neoplasm therapies. Focus on anagrelide.

Antelo ML, de Las Heras N, Gonzalez Porras JR, Kerguelen A, Raya JM.

Expert Rev Hematol. 2015 Dec;8(6):819-35. doi: 10.1586/17474086.2015.1088779. Epub 2015 Sep 14. Review.

PMID:
26368319
28.

Thrombosis secondary to acute hypernatraemia after liver hydatid cyst surgery.

Conde MP, Rodríguez MÁ, López JM, González-Porras JR.

Blood Coagul Fibrinolysis. 2015 Sep;26(6):695-8. doi: 10.1097/MBC.0000000000000328.

PMID:
26154611
29.

Incidence and risk factors for life-threatening bleeding after allogeneic stem cell transplant.

Labrador J, López-Corral L, Vazquez L, Sánchez-Guijo F, Guerrero C, Sánchez-Barba M, Lozano FS, Alberca I, Del Cañizo MC, Caballero D, González-Porras JR.

Br J Haematol. 2015 Jun;169(5):719-25. doi: 10.1111/bjh.13344. Epub 2015 Mar 26.

PMID:
25817436
30.

Oral anticoagulation to prevent thrombosis recurrence in polycythemia vera and essential thrombocythemia.

Hernández-Boluda JC, Arellano-Rodrigo E, Cervantes F, Alvarez-Larrán A, Gómez M, Barba P, Mata MI, González-Porras JR, Ferrer-Marín F, García-Gutiérrez V, Magro E, Moreno M, Kerguelen A, Pérez-Encinas M, Estrada N, Ayala R, Besses C, Pereira A; Grupo Español de Enfermedades Mieloproliferativas Filadelfia Negativas (GEMFIN).

Ann Hematol. 2015 Jun;94(6):911-8. doi: 10.1007/s00277-015-2330-2. Epub 2015 Feb 14.

PMID:
25680896
31.

Slow femoral venous flow and venous thromboembolism following inguinal hernioplasty in patients without or with low molecular weight heparin prophylaxis.

Lozano FS, Sánchez-Fernández J, González-Porras JR, García-Alovio J, Santos JA, Mateos R, Alberca I.

Hernia. 2015 Dec;19(6):901-8. doi: 10.1007/s10029-015-1353-x. Epub 2015 Feb 8.

PMID:
25662843
32.

Use of eltrombopag after romiplostim in primary immune thrombocytopenia.

González-Porras JR, Mingot-Castellano ME, Andrade MM, Alonso R, Caparrós I, Arratibel MC, Fernández-Fuertes F, Cortti MJ, Pascual C, Sánchez-González B, Bernat S, Fuertes-Palacio MA, Vázquez-Paganini JA, Olivera PE, Alvarez-Román MT, Jarque I, Cortés M, Martínez-Robles V, Díaz-Gálvez FJ, Calbacho M, Fernández-Miñano C, Garcia-Frade J, González-López TJ.

Br J Haematol. 2015 Apr;169(1):111-6. doi: 10.1111/bjh.13266. Epub 2014 Dec 18.

PMID:
25521630
33.

The role of the TERC-63G>A and TERT-1327C>T telomerase polymorphisms in the study of men with acute coronary syndrome.

Perez-Rivera JA, Pabon-Osuna P, Cieza-Borrella C, Lugo-Godoy C, Martin-Herrero F, Gonzalez-Porras JR, Sanchez-Fernandez PL, Gonzalez-Sarmiento R.

Minerva Cardioangiol. 2015 Dec;63(6):467-74. Epub 2014 Dec 17.

PMID:
25516136
34.

Multivariable time-dependent analysis of the impact of azacitidine in patients with lower-risk myelodysplastic syndrome and unfavorable specific lower-risk score.

Falantes J, Delgado RG, Calderón-Cabrera C, Márquez-Malaver FJ, Valcarcel D, de Miguel D, Bailén A, Bargay J, Bernal T, González-Porras JR, Tormo M, Ramos F, Andreu R, Xicoy B, Nomdedeu B, Brunet S, Sánchez J, Jurado AF, Bonanad S, Pérez-Simón JA, Sanz G; Spanish Group of Myelodysplastic Syndromes (GESMD).

Leuk Res. 2015 Jan;39(1):52-7. doi: 10.1016/j.leukres.2014.10.004. Epub 2014 Oct 30.

PMID:
25487012
35.

Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia.

González-López TJ, Pascual C, Álvarez-Román MT, Fernández-Fuertes F, Sánchez-González B, Caparrós I, Jarque I, Mingot-Castellano ME, Hernández-Rivas JA, Martín-Salces M, Solán L, Beneit P, Jiménez R, Bernat S, Andrade MM, Cortés M, Cortti MJ, Pérez-Crespo S, Gómez-Núñez M, Olivera PE, Pérez-Rus G, Martínez-Robles V, Alonso R, Fernández-Rodríguez A, Arratibel MC, Perera M, Fernández-Miñano C, Fuertes-Palacio MA, Vázquez-Paganini JA, Gutierrez-Jomarrón I, Valcarce I, de Cabo E, Sainz A, Fisac R, Aguilar C, Paz Martínez-Badas M, Peñarrubia MJ, Calbacho M, de Cos C, González-Silva M, Coria E, Alonso A, Casaus A, Luaña A, Galán P, Fernández-Canal C, Garcia-Frade J, González-Porras JR.

Am J Hematol. 2015 Mar;90(3):E40-3. doi: 10.1002/ajh.23900. Epub 2015 Jan 16.

36.

Relative value of the Ankle-Brachial Index of intermittent claudication.

Lozano FS, March JR, González-Porras JR, Carrasco E, Lobos JM, Ros E.

Int J Clin Pract. 2014 Dec;68(12):1478-82. doi: 10.1111/ijcp.12499. Epub 2014 Oct 4.

PMID:
25283365
37.

Differences between women and men with intermittent claudication: a cross-sectional study.

Lozano FS, González-Porras JR, March JR, Carrasco E, Lobos JM; VITAL Investigators.

J Womens Health (Larchmt). 2014 Oct;23(10):834-41. doi: 10.1089/jwh.2013.4653. Epub 2014 Sep 19.

PMID:
25238019
38.

Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus.

Labrador J, López-Corral L, López-Godino O, Vázquez L, Cabrero-Calvo M, Pérez-López R, Díez-Campelo M, Sánchez-Guijo F, Pérez-López E, Guerrero C, Alberca I, Del Cañizo MC, Pérez-Simón JA, González-Porras JR, Caballero D.

Bone Marrow Transplant. 2014 May;49(5):684-90. doi: 10.1038/bmt.2014.17. Epub 2014 Feb 24.

39.

Diabetes mellitus and intermittent claudication: a cross-sectional study of 920 claudicants.

Lozano FS, González-Porras JR, March JR, Lobos JM, Carrasco E, Ros E.

Diabetol Metab Syndr. 2014 Feb 17;6(1):21. doi: 10.1186/1758-5996-6-21.

40.

Sustained response after discontinuation of short-and medium-term treatment with eltrombopag in patients with immune thrombocytopenia.

González-López TJ, Sánchez-González B, Pascual C, Arefi M, de Cabo E, Alonso A, Martín-Salces M, Jiménez-Bárcenas R, Calbacho M, Galan P, Barez A, González-Porras JR.

Platelets. 2015;26(1):83-6. doi: 10.3109/09537104.2013.870987. Epub 2014 Feb 5.

PMID:
24499036
41.

Effect of telomere length on prognosis in men with acute coronary syndrome.

Perez-Rivera JA, Pabon-Osuna P, Cieza-Borrella C, Duran-Bobin O, Martin-Herrero F, Gonzalez-Porras JR, Gonzalez-Sarmiento R.

Am J Cardiol. 2014 Feb 1;113(3):418-21. doi: 10.1016/j.amjcard.2013.10.009. Epub 2013 Nov 7.

PMID:
24290493
42.

Monitoring the practice of vascular surgery: findings from a national registry (1996-2011).

Lozano FS, Marinello J, Moreno RM, Aguilar MD, López-Quintana A, Gonzalez-Porras JR, Alvarez J, Giménez-Gaibar A, Alguacil R, Cairols MA, Marco-Luque MA, Vaquero F, Callejas JM.

World J Surg. 2014 Jan;38(1):241-51. doi: 10.1007/s00268-013-2272-6.

PMID:
24170151
43.

National Consensus on the Diagnosis, Risk Stratification and Treatment of Patients with Pulmonary Embolism. Spanish Society of Pneumology and Thoracic Surgery (SEPAR). Society Española Internal Medicine (SEMI). Spanish Society of Thrombosis and Haemostasis (SETH). Spanish Society of Cardiology (ESC). Spanish Society of Medicine Accident and Emergency (SEMES). Spanish Society of Angiology and Surgery Vascular (SEACV).

Uresandi F, Monreal M, García-Bragado F, Domenech P, Lecumberri R, Escribano P, Zamorano JL, Jiménez S, Ruiz-Artacho P, Lozano F, Romera A, Jiménez D; National Consensus on Diagnosis, Risk Stratification and Treatment of Patients With Pulmonary Thromboembolism, Bellmunt S, Cuenca J, Fernández Á, Fernández F, Ibáñez V, Lozano F, March JR, Romera A, Almenar L, Castro A, Escribano P, Lázaro M, Luis Zamorano J, Alonso JR, Ramón Casal J, Miguel Franco J, Jiménez S, Merlo M, Perales R, Piñera P, Ruiz-Artacho P, Suero C, Barba R, Fernández-Capitán C, García-Bragado F, Gómez V, Monreal M, Nieto JA, Riera-Mestre A, Suárez C, Trujillo-Santos J, Conget F, Jara L, Jiménez D, Lobo JL, de Miguel J, Nauffal D, Oribe M, Otero R, Uresandi F, Domenech P, González-Porras JR, Lecumberri R, Llamas P, Mingot E, Pina E, Rodríguez-Martorell J; : Spanish Society of Pneumology and Thoracic Surgery (SEPAR); Society Española Internal Medicine (SEMI); Spanish Society of Thrombosis and Haemostasis (SETH); Spanish Society of Cardiology (ESC); Spanish Society of Medicine Accident and Emergency (SEMES); Spanish Society of Angiology and Surgery Vascular (SEACV).

Arch Bronconeumol. 2013 Dec;49(12):534-47. doi: 10.1016/j.arbres.2013.07.008. Epub 2013 Sep 14. No abstract available.

44.

Validation of the Walking Impairment Questionnaire for Spanish patients.

Lozano FS, March JR, González-Porras JR, Carrasco E, Lobos JM, Areitio-Aurtena A.

Vasa. 2013 Sep;42(5):350-6. doi: 10.1024/0301-1526/a000300.

PMID:
23989070
45.

Quality of life in patients with chronic venous disease: influence of the socio-demographical and clinical factors.

Lozano Sánchez FS, Sánchez Nevarez I, González-Porras JR, Marinello Roura J, Escudero Rodríguez JR, Díaz Sánchez S, Carrasco Carrasco E; Sociedad Española de Angiología y Cirugía Vascular (SEACV); Sociedad Española de Médicos de Atención Primaria (SEMERGEN); Sociedad Española de Medicina Familiar y Comunitaria (SEMFYC).

Int Angiol. 2013 Aug;32(4):433-41.

PMID:
23822947
46.

Safety and efficacy of splenectomy in over 65-yrs-old patients with immune thrombocytopenia.

Gonzalez-Porras JR, Escalante F, Pardal E, Sierra M, Garcia-Frade LJ, Redondo S, Arefi M, Aguilar C, Ortega F, de Cabo E, Fisac RM, Sanz O, Esteban C, Alberca I, Sanchez-Barba M, Santos MT, Fernandez A, Gonzalez-Lopez TJ; Grupo de Trombosis y Hemostasia de Castilla y León.

Eur J Haematol. 2013 Sep;91(3):236-41. doi: 10.1111/ejh.12146. Epub 2013 Jul 7.

PMID:
23679653
47.

Characterization and prognostic implication of 17 chromosome abnormalities in myelodysplastic syndrome.

Sánchez-Castro J, Marco-Betés V, Gómez-Arbonés X, Arenillas L, Valcarcel D, Vallespí T, Costa D, Nomdedeu B, Jimenez MJ, Granada I, Grau J, Ardanaz MT, de la Serna J, Carbonell F, Cervera J, Sierra A, Luño E, Cervero CJ, Falantes J, Calasanz MJ, González-Porrás JR, Bailén A, Amigo ML, Sanz G, Solé F.

Leuk Res. 2013 Jul;37(7):769-76. doi: 10.1016/j.leukres.2013.04.010. Epub 2013 Apr 29.

PMID:
23639672
48.

Venous leg ulcer in the context of chronic venous disease.

Lozano Sánchez FS, Marinel lo Roura J, Carrasco Carrasco E, González-Porras JR, Escudero Rodríguez JR, Sánchez Nevarez I, Díaz Sánchez S; Sociedades Españolas de Angiología y Cirugía Vascular (SEACV); Capítulo Español de Flebologia, the Médicos de Atención Primaria (SEMERGEN); Medicina Familiar y Comunitaria (SemFYC).

Phlebology. 2014 May;29(4):220-6. doi: 10.1177/0268355513480489. Epub 2013 May 6.

PMID:
23538963
49.

Negative impact of deep venous thrombosis on chronic venous disease.

Lozano Sánchez FS, González-Porras JR, Díaz Sánchez S, Marinel Lo Roura J, Sánchez Nevarez I, Carrasco EC, Escudero Rodríguez JR; C-VIVES Study investigators.

Thromb Res. 2013 Apr;131(4):e123-6. doi: 10.1016/j.thromres.2013.01.011. Epub 2013 Feb 4.

PMID:
23384613
50.

Immature platelet fraction: a new prognostic marker in acute coronary syndrome.

López-Jiménez RA, Martín-Herrero F, González-Porras JR, Sánchez-Barba M, Martín-Luengo C, Pabón-Osuna P.

Rev Esp Cardiol (Engl Ed). 2013 Feb;66(2):147-8. doi: 10.1016/j.rec.2012.05.014. Epub 2012 Sep 5. No abstract available.

PMID:
24775393

Supplemental Content

Loading ...
Support Center